Human mucosal and systemic immune system

The human mucosal and systemic immune systems comprise a complex, integrated network of lymphoid tissues, cells, and soluble factors that protect the host from pathogenic invasion while maintaining tolerance to harmless environmental antigens (Janeway et al., 2001, Immunobiology). The mucosal immune system is the largest component, protecting barrier surfaces such as the gastrointestinal and respiratory tracts through specialized mechanisms like secretory IgA production and mucosal-associated lymphoid tissue (MALT) (Mowat & Agace, 2014, Nature Reviews Immunology). The systemic immune system, involving the bone marrow, thymus, spleen, and peripheral lymph nodes, provides broader surveillance and memory against systemic threats (NIH, 2023, National Institute of Allergy and Infectious Diseases). Dysregulation of these systems leads to diverse pathologies, including inflammatory bowel disease, asthma, and systemic lupus erythematosus (Parkin & Cohen, 2001, The Lancet). Therapeutic strategies often involve targeting specific molecular components within these systems, such as integrins for mucosal-specific trafficking or TNF-alpha for systemic inflammation, to restore immunological balance (Neurath, 2014, Nature Reviews Immunology).

Other names

Mucosal immune systemSystemic immune systemHost defense systemImmune network

Drugs targeting these systems act through diverse mechanisms, including the inhibition of pro-inflammatory cytokines like TNF-alpha blockers, blockade of lymphocyte trafficking to specific tissues like alpha-4-beta-7 integrin antagonists, and modulation of T-cell or B-cell activation and proliferation (StatPearls, 2023, Immunosuppression).